Beyond Inhalers: How IL-4/IL-13 Biologics Are Re-Engineering Severe...

added blog Other

2026-10-01 12:26:18 -

Beyond Inhalers: How IL-4/IL-13 Biologics Are Re-Engineering Severe COPD Treatment Strategy

The Chronic Obstructive Pulmonary Disease (COPD) Drugs Market is undergoing a fundamental clinical shift from traditional maintenance bronchodilators toward targeted biologics and fixed-dose triple combination therapies, according to the latest exhaustive market intelligence report released by Stellar Market Research. Valued at USD 21.27 Billion in 2025, the global market is set to...

0 Comments 0 Shares 23 Views 0 Reviews